26 research outputs found
The wicked problem of invasive species management in India
Globally, climate change has been recognized as a critical threat to social and ecological systems. As climate change affects larger portions of our world, acknowledging the need to adapt to the change, and to build more resilient systems, becomes imperative. These challenges bear further complexity in developing countries such as India, which is characterised by its growing population, rapid economic growth, rampant socio-economic inequality and ecological and socio-cultural diversity
A Study to Assess the Level of Depression and Anxiety among Woman with Polycystic Ovarian Disorder in Selected Hospital Nadiad City Gujarat
Background: Polycystic Ovarian Disorder Is The Most Common Endocrine Abnormality In Women Of Reproductive Age It Is A Health Problem That Affect 1 In 10 Women Of Child Bearing Age (15-49 Year). According To Indian Fertility Society Prevalence Of Pcod Range From 3.71% To 22.5% Women With Pcod Have Experienced Adverse Social, Physical, Emotional, And Psychological Consequences And They Are At Risk Of Developing Depression, Anxiety, Sadness, And Loneliness, Which Had Negative Impact On Their Health. Aims: The Main Aim Of The Study Is To Assess The Level Of Depression And Anxiety Among Women With Polycystic Ovarian Disorder In Selected Hospital In Nadiad City, Gujarat. Objectives To Assess The Level Of Depression In Women With Pcod In Selected Hospital Of Nadiad City Gujarat To Assess The Level Of Anxiety In Women With Pcod In Selected Hospital Of Nadiad City Gujarat. To Find Out The Association Between Level Of Depression And Anxiety Among Women With Pcod In A Selected Demographic Variables. Methodology: A Cross Sectional And Descriptive Study Designed Was Used By A Researcher. 100 Women Who Having Pcod Were Selected As A Sample. Sample Were Selected From Samju Laxmi Maternity Hospital And Akshar Hospital In Nadiad City Gujarat , Data Were Analyzed By Using Descriptive And Inferential Statistic And Frequency And Percentage, Table, Graph Etc., Were Used To Represent The Statistical Data. Result: In All 100 Women With Pcod Were Entered Into This Study In Which 36% Pcod Women Have No Depression, 49% Pcod Women Have Mild Depression, 8% Pcod Women Have Moderate Depression 7%, Pcod Women Have Severe Depression. Which Is Associated With Their Demographic Variable I.E. Age, Type Of Family. In All 100 Women With Pcod 7% Women Have No Anxiety ,24% Women Have Mild To Moderate Anxiety Level ,52% Women Have Moderate To Severe Anxiety And 7% Women Have Severe Anxiety. Which Is Associated With Their Demographic Variables I.E. Age, Marital Status, Have A Child?, Source Of Information About Pcod, Duration Of Pcod?, Duration Of Treatment.Conclusion :The Result Of Present Study Shows That The Pcod Women Have A Psychological Impact In Which There Is Presence Of Mild, Moderate And Severe Level Of Depression And Anxiety In Women With Pcod
NASYA-MOST VITAL THERAPEUTIC INTERVENTION OF PANCHAKARMA-A REVIEW
Ayurveda is a Science and art of appropriate living which helps to achieve longevity. Panchakarma present a unique approach of Ayurveda to therapy with specially designed five procedures of internal purification of the body. One of the Panchakarma, the Nasyakarma is considered the best and the most specific procedure for disease of Urdhvajatrugatarogas like Pratishyay, Shirahshoola etc. It is also useful in other systemic diseases like Ardita, Kampavata. According to Ayurveda, the nose is the gate way to Shirah. So, systemically performed Nasyakarma cures almost all the diseases of Urdhvajatrugata rogas. Other procedures of Panchakarma are also very effective in numerous diseases according to condition but Nasya Karma is very easy to perform and there are no many strict regimens to follow during Nasya Karma but it will give effectual results in loads of diseases due to direct contact with nerve terminals by the nasal mucosa. So, it is demand of time to know about Nasyakarma and its importance. In this direction, to evaluate the actual efficacy of different Ayurveda treatment modalities; few works on Nasya Karma are compiled here. In current attempt, it has been planned to review as such works done on Nasyakarma. By this Present study it can be stated that in various diseases Nasya Karma is found to be significantly effective. It proved to be a better therapy as compared to only oral drug because it provides affect for longer duration than oral drug
Recommended from our members
Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.
BackgroundRapid spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and concern for viral transmission by ambulatory patients with minimal to no symptoms underline the importance of identifying early or subclinical symptoms of coronavirus disease 2019 (COVID-19) infection. Two such candidate symptoms include anecdotally reported loss of smell and taste. Understanding the timing and association of smell/taste loss in COVID-19 may help facilitate screening and early isolation of cases.MethodsA single-institution, cross-sectional study evaluating patient-reported symptoms with a focus on smell and taste was conducted using an internet-based platform on adult subjects who underwent testing for COVID-19. Logistic regression was employed to identify symptoms associated with COVID-19 positivity.ResultsA total of 1480 patients with influenza-like symptoms underwent COVID-19 testing between March 3, 2020, and March 29, 2020. Our study captured 59 of 102 (58%) COVID-19-positive patients and 203 of 1378 (15%) COVID-19-negative patients. Smell and taste loss were reported in 68% (40/59) and 71% (42/59) of COVID-19-positive subjects, respectively, compared to 16% (33/203) and 17% (35/203) of COVID-19-negative patients (p < 0.001). Smell and taste impairment were independently and strongly associated with COVID-19 positivity (anosmia: adjusted odds ratio [aOR] 10.9; 95% CI, 5.08-23.5; ageusia: aOR 10.2; 95% CI, 4.74-22.1), whereas sore throat was associated with COVID-19 negativity (aOR 0.23; 95% CI, 0.11-0.50). Of patients who reported COVID-19-associated loss of smell, 74% (28/38) reported resolution of anosmia with clinical resolution of illness.ConclusionIn ambulatory individuals with influenza-like symptoms, chemosensory dysfunction was strongly associated with COVID-19 infection and should be considered when screening symptoms. Most will recover chemosensory function within weeks, paralleling resolution of other disease-related symptoms
Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers
© 2018 Hilfenhaus et al.Through multiple cell–cell and cell–matrix interactions, epithelial and endothelial sheets form tight barriers. Modulators of the cytoskeleton contribute to barrier stability and act as rheostats of vascular permeability. In this study, we sought to identify cytoskeletal regulators that underlie barrier diversity across vessels. To achieve this, we correlated functional and structural barrier features to gene expression of endothelial cells (ECs) derived from different vascular beds. Within a subset of identified candidates, we found that the guanosine nucleotide exchange factor Vav3 was exclusively expressed by microvascular ECs and was closely associated with a high-resistance barrier phenotype. Ectopic expression of Vav3 in large artery and brain ECs significantly enhanced barrier resistance and cortical rearrangement of the actin cytoskeleton. Mechanistically, we found that the barrier effect of Vav3 is dependent on its Dbl homology domain and downstream activation of Rap1. Importantly, inactivation of Vav3 in vivo resulted in increased vascular leakage, highlighting its function as a key regulator of barrier stability.Deutsche Forschungsgemeinschaft (STE 2045/1-1) Fundación Ramón Areces (NO AWARD) Ministerio de EconomÃa y Competitividad (NO AWARD) National Institutes of Health (P40OD018537) Worldwide Cancer Research (13-0170
Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers
[EN]Through multiple cell-cell and cell-matrix interactions, epithelial and endothelial sheets form tight barriers. Modulators of the cytoskeleton contribute to barrier stability and act as rheostats of vascular permeability. In this study, we sought to identify cytoskeletal regulators that underlie barrier diversity across vessels. To achieve this, we correlated functional and structural barrier features to gene expression of endothelial cells (ECs) derived from different vascular beds. Within a subset of identified candidates, we found that the guanosine nucleotide exchange factor Vav3 was exclusively expressed by microvascular ECs and was closely associated with a high-resistance barrier phenotype. Ectopic expression of Vav3 in large artery and brain ECs significantly enhanced barrier resistance and cortical rearrangement of the actin cytoskeleton. Mechanistically, we found that the barrier effect of Vav3 is dependent on its Dbl homology domain and downstream activation of Rap1. Importantly, inactivation of Vav3 in vivo resulted in increased vascular leakage, highlighting its function as a key regulator of barrier stability. © 2018 Hilfenhaus et al
Assessment of patient recognition of coronavirus disease 2019 (COVID-19)-associated olfactory loss and recovery: a longitudinal study.
Chromomycin, an antibiotic produced by Streptomyces flaviscleroticus might play a role in the resistance to oxidative stress and is essential for viability in stationary phase
The well-known role of antibiotics in killing sensitive organisms has been challenged by the effects they exert at subinhibitory concentrations. Unfortunately, there are very few published reports on the advantages these molecules may confer to their producers. This study describes the construction of a genetically verified deletion mutant of Streptomyces flaviscleroticus unable to synthesize chromomycin. This mutant was characterized by a rapid loss of viability in stationary phase that was correlated with high oxidative stress and altered antioxidant defences. Altered levels of key metabolites in the mutant signalled a redistribution of the glycolytic flux toward the PPP to generate NADPH to fight oxidative stress as well as reduction of ATP-phosphofructokinase and Krebs cycle enzymes activities. These changes were correlated with a shift in the preference for carbon utilization from glucose to amino acids. Remarkably, chromomycin at subinhibitory concentration increased longevity of the non-producer and restored most of the phenotypic features’ characteristic of the wild type strain. Altogether these observations suggest that chromomycin may have antioxidant properties that would explain, at least in part, some of the phenotypes of the mutant. Our observations warrant reconsideration of the secondary metabolite definition and raise the possibility of crucial roles for their producers
Recommended from our members
Assessment of patient recognition of coronavirus disease 2019 (COVID-19)-associated olfactory loss and recovery: a longitudinal study.
BACKGROUND: The clinical course of coronavirus disease 2019 (COVID-19) olfactory dysfunction remains poorly characterized, often limited by self-reported measures. Given the logistical challenges of psychophysical testing, understanding the longitudinal relationship between self-reported and quantitative measures can help accurately identify patients with persistent olfactory dysfunction. This study aimed to longitudinally correlate measured and subjective olfactory function in COVID-19 subjects. METHODS: A prospective, longitudinal study evaluating subjective and measured olfaction was conducted on ambulatory COVID-19 subjects. Olfaction scores were obtained using a visual analogue scale (VAS) (0 = anosmia, 10 = normosmia) and the validated 12-item Brief Smell Identification Test (BSIT). Weekly testing was performed until recovery (BSIT ≥ 9/12 and/or VAS = 10/10) or study completion. RESULTS: Eighty-six polymerase chain reaction (PCR)-positive COVID-19 subjects were recruited ≤3 days from diagnosis and 52 completed longitudinal testing. Among those with self-reported smell loss at recruitment, similar levels (75.8%) of objective (BSIT ≥ 9/12) and subjective recovery were obtained using a VAS cutoff ≥8, yet only 30.3% reported complete subjective recovery (VAS = 10). Median times to objective and complete subjective olfactory recovery were 12 ± 2.3 and 24 ± 3.5 days, respectively. Although both measures showed chemosensory improvement, the distributions of objective and full subjective olfactory recovery differed significantly (log rank test χ2 = 6.46, degrees of freedom [df] = 1, p = 0.011). Overall correlation between BSIT and VAS scores was moderate to strong across longitudinal follow-up (rs = 0.41-0.65). CONCLUSION: Self-reported and psychophysically measured COVID-19 olfactory dysfunction improve at similar levels and are moderately correlated longitudinally, yet there is a significant delay in complete subjective recovery. Psychophysical testing in conjunction with qualitative assessments may be considered for counseling and follow-up of patients with COVID-19 smell loss
Persistent Smell Loss Following Undetectable SARS-CoV-2
The association of smell and taste loss with COVID-19 has been well demonstrated with high prevalence rates. In certain cases, chemosensory loss may be the only symptom of COVID-19 and may linger while other symptoms have resolved. The significance of persistent smell and taste loss and its relationship to ongoing viral shedding has yet to be investigated. In this cross-sectional study, of the 316 laboratory test-confirmed COVID-19 cases at our institution, 46 had subsequent test-based confirmation of viral clearance with 2 consecutive negative RT-PCR test results (reverse transcriptase polymerase chain reaction). Olfactory dysfunction was reported by 50% of the patients (23 of 46), with 78% (18 of 23) having subjective persistent smell loss despite negative RT-PCR test results. These preliminary data demonstrate the persistence of self-reported smell loss despite otherwise clinical resolution and undetectable nasal viral RNA